Adding Interventional DED Treatment to Your Practice - Summary - MDSpire
Advertisement
Adding Interventional DED Treatment to Your Practice
Interventional treatment for DED before refractive surgery biometry allows practices to offer options like advanced-technology intraocular lenses to more patients.
To promote the adoption of interventional treatments for dry eye disease (DED) in clinical practice, emphasizing their potential to improve patient outcomes.
Key Findings:
Interventional treatments reduce patient compliance burdens associated with topical therapies, leading to better outcomes.
Lacrimal occlusion with hyaluronic acid gel provides immediate symptomatic relief and improves compliance, making it a preferred first-line treatment.
TARGET therapy shows superior outcomes compared to traditional therapies in clinical studies, enhancing patient satisfaction.
Interpretation:
Adopting an interventional approach to DED can enhance patient outcomes, streamline practice operations, and improve overall treatment efficacy, making it essential for modern ophthalmic practices.
Limitations:
Not all treatments may be suitable for every patient, necessitating careful assessment.
Implementation requires training and restructuring of practice workflows, which may pose initial challenges.
Conclusion:
Transitioning to an interventional treatment model for DED can significantly benefit both patients and ophthalmic practices, making it a timely and necessary shift.
